Skip to main content
Clinical Trials/DRKS00034589
DRKS00034589
Recruiting
未知

E-monitoring to increase treatment quality and functional capacity in young rheumatoid arthritis patients with high disease activity - Rhe-Turn

Technische Universität München, TUM School of Medicine and Health, Department Sport and Health Sciences, Professur für Biomechanik im Sport0 sites185 target enrollmentJuly 4, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
M08.8
Sponsor
Technische Universität München, TUM School of Medicine and Health, Department Sport and Health Sciences, Professur für Biomechanik im Sport
Enrollment
185
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 4, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Technische Universität München, TUM School of Medicine and Health, Department Sport and Health Sciences, Professur für Biomechanik im Sport

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of JIA according to ILAR criteria
  • active JIA disease
  • at least moderate disease activity according to cJADAS10 (clinical Juvenile Arthritis Disease Activity Score for 10 joints;\>1\.5 for oligoarthritis; \>2\.5 for polyarthritis)
  • PWC test feasible
  • German\-speaking
  • written consent for study participation (patient and parent/guardian)
  • access to digital devices (smartphone, tablet)

Exclusion Criteria

  • Non\-infectious fever lasting more than 5 days and/or systemic JIA
  • Neurological, cardiac, orthopaedic, metabolic or pulmonary disease limiting physical activity
  • Pregnancy / breastfeeding
  • Chronic pain disorder
  • Simultaneous participation in behavioral or exercise therapy intervention studies
  • Simultaneous participation in a pharmaceutical intervention study
  • Due to language or mental barriers, patients and/or their relatives are unable to understand the study content and the information provided

Outcomes

Primary Outcomes

Not specified

Similar Trials